SCHEMBL7409252

SCHEMBL7409252

Nc1nccc2[nH]c(C(Cc3ccc4cncnc4c3)N3CCNCC3=O)cc12

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
F10 P00742 7/20 0.32
EGFR P00533 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7409241 0.84 F10 (0.40) F10
SCHEMBL7404837 0.77 F10 (0.41) F10
SCHEMBL7374157 0.74 F10 (0.32) F10
SCHEMBL7407779 0.72 F10 (0.42) F10
SCHEMBL7407923 0.71 EGFR (0.36) EGFR
SCHEMBL7588660 0.70 F10 (0.46) F10
SCHEMBL7375611 0.70 CDK2 (0.31)
SCHEMBL7407384 0.69 P2RX7 (0.33)
SCHEMBL7370841 0.69
SCHEMBL27527040 0.68 F10 (0.40) F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1051176-A4 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS AVENTIS PHARM PROD INC (US) 2002-06-12 EP disclosed
EP-1051176-A1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS Aventis Pharmaceuticals Products Inc. (US) 2000-11-15 EP disclosed
WO-1999037304-A1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS AVENTIS PHARMACEUTICALS PRODUCTS INC. (US) 1999-07-29 WO disclosed